Effect of HCO1100 on Cardiovascular Function
Not Applicable
Terminated
- Conditions
- Chronic Kidney FailureCardiovascular Disease
- Interventions
- Device: HCO 1100
- First Posted Date
- 2011-06-02
- Last Posted Date
- 2025-03-13
- Lead Sponsor
- Vantive Health LLC
- Target Recruit Count
- 10
- Registration Number
- NCT01363921
- Locations
- 🇩🇪
Med. Klinik II, Nephrologie und med. Immunologie, Universitätsklinikum Aachen, Aachen, NRW, Germany
HepZero:Heparin Free Dialysis With Evodial
Not Applicable
Completed
- Conditions
- Chronic Kidney DiseasePatients Requiring Heparin Free Dialysis Treatments
- Interventions
- Device: EvodialOther: Heparin free dialysis technique
- First Posted Date
- 2011-03-18
- Last Posted Date
- 2025-03-14
- Lead Sponsor
- Vantive Health LLC
- Target Recruit Count
- 265
- Registration Number
- NCT01318486
- Locations
- 🇧🇪
Erasme Hospital, Brussels, Belgium
🇫🇷CHU Brabois, Nancy, France
🇨🇦George Dumont Hospital, Moncton, New Brunswick, Canada
Safety During Use of Paediatric Triple Chamber Bag Formulas
Phase 3
Completed
- Conditions
- Infant Nutrition DisordersInfant, Premature, DiseasesDigestive System Disorders
- Interventions
- Drug: Ped3CB
- First Posted Date
- 2011-02-25
- Last Posted Date
- 2011-02-25
- Lead Sponsor
- Baxter Healthcare Corporation
- Target Recruit Count
- 161
- Registration Number
- NCT01304394
- Locations
- 🇫🇷
Hôpital Necker, Paris, France
🇫🇷Hôpital Pontchaillou, Rennes, France
🇫🇷Hôpital HFME - Groupement Hospitalier Est, Bron, France
Fibrin Sealant VH S/D 500 S-apr in Hepatic Resection
Phase 2
Completed
- Conditions
- Bleeding (Oozing) in Hepatic Resection
- Interventions
- Other: Manual compression
- First Posted Date
- 2010-11-19
- Last Posted Date
- 2013-02-20
- Lead Sponsor
- Baxter Healthcare Corporation
- Target Recruit Count
- 70
- Registration Number
- NCT01244425
Intravenous (IV) Solutions for Dehydration in Children With Gastroenteritis
Phase 4
Terminated
- Conditions
- DehydrationGastroenteritis
- Interventions
- Drug: multiple electrolyte solutionDrug: saline
- First Posted Date
- 2010-11-04
- Last Posted Date
- 2018-04-26
- Lead Sponsor
- Baxter Healthcare Corporation
- Target Recruit Count
- 100
- Registration Number
- NCT01234883
- Locations
- 🇨🇦
British Columbia Children's Hospital, Vancouver, British Columbia, Canada
🇺🇸Emory University/Children's Healthcare of Atlanta, Atlanta, Georgia, United States
🇨🇦Alberta Children's Hospital, Calgary, Alberta, Canada
Dianeal, Extraneal, Nutrineal (D-E-N) Versus Dianeal Only in Diabetic Continuous Ambulatory Peritoneal Dialysis (CAPD) Patients
Phase 3
Completed
- Conditions
- End Stage Renal Disease (ESRD)DiabetesCAPD
- Interventions
- Drug: Dianeal, Extraneal, Nutrineal
- First Posted Date
- 2010-10-13
- Last Posted Date
- 2025-03-13
- Lead Sponsor
- Vantive Health LLC
- Target Recruit Count
- 71
- Registration Number
- NCT01219959
- Locations
- 🇨🇴
RTS Ltda H.U.V, Cali, Colombia
🇨🇴RTS Ltda STR del Valle, Cali, Colombia
🇨🇴RTS Ltda Versalles, Cali, Colombia
Gambro AK200 ULTRA Hemodiafiltration Study
Not Applicable
Completed
- Conditions
- Chronic Renal Failure
- First Posted Date
- 2010-09-16
- Last Posted Date
- 2025-03-11
- Lead Sponsor
- Vantive Health LLC
- Target Recruit Count
- 14
- Registration Number
- NCT01202708
- Locations
- 🇺🇸
George Washington University Medical Center, Washington, District of Columbia, United States
A Pilot Study of a Heparin Dosing Algorithm for Hemodialysis
Not Applicable
Completed
- Conditions
- Renal Failure Chronic Requiring Hemodialysis
- Interventions
- Procedure: Heparin dose titration
- First Posted Date
- 2010-08-13
- Last Posted Date
- 2025-03-13
- Lead Sponsor
- Vantive Health LLC
- Target Recruit Count
- 5
- Registration Number
- NCT01181544
- Locations
- 🇺🇸
University of Louisville, Louisville, Kentucky, United States
Efficacy and Time and Resources for Hylenex-facilitated SC Rehydration Versus ORT for Dehydrated Children in the Emergency Department (ED)
Phase 4
Withdrawn
- Conditions
- Dehydration
- Interventions
- Other: Oral rehydration fluid
- First Posted Date
- 2010-05-11
- Last Posted Date
- 2017-05-08
- Lead Sponsor
- Baxter Healthcare Corporation
- Registration Number
- NCT01120431
Study of In-line Pressure Using Various Techniques of Subcutaneous Administration of Fluids Enabled by Human Recombinant Hyaluronidase (INFUSE-AT1A)
Phase 4
Terminated
- Conditions
- Dehydration
- Interventions
- Drug: Subcutaneous HYLENEX (recombinant human hyaluronidase) and Lactated Ringer's solution
- First Posted Date
- 2010-05-04
- Last Posted Date
- 2011-10-24
- Lead Sponsor
- Baxter Healthcare Corporation
- Target Recruit Count
- 20
- Registration Number
- NCT01116102
- Locations
- 🇺🇸
Kendle International, Inc. Drug Study Unit, Morgantown, West Virginia, United States
© Copyright 2025. All Rights Reserved by MedPath